Plitidepsin for the management of a cancer patient infected with SARS-CoV-2 while receiving chemotherapy

Ann Oncol. 2021 Oct;32(10):1295-1297. doi: 10.1016/j.annonc.2021.07.003. Epub 2021 Jul 7.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / therapeutic use
  • COVID-19 Drug Treatment*
  • Depsipeptides / therapeutic use*
  • Humans
  • Neoplasms* / drug therapy
  • Peptides, Cyclic / therapeutic use*

Substances

  • Antineoplastic Agents
  • Depsipeptides
  • Peptides, Cyclic
  • plitidepsin